Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanotechnology Now's columnist Lynn L. Bergeson will speak at the fifth international symposium on nanotechnology, occupational and environmental health

Lynn L. Bergeson
Lynn L. Bergeson

Abstract:
Bergeson & Campbell, P.C. (B&C), B&C Consortia Management, L.L.C. (BCCM), The Acta Group, L.L.C. (Acta), and The Acta Group EU, Ltd (Acta EU) are pleased to announce that on August 9, 2011, Lynn L. Bergeson will speak in Boston, Massachusetts, at the Fifth International Symposium on Nanotechnology, Occupational and Environmental Health (NanOEH) on key policy and regulatory considerations related to nanotechnology. The program will focus on life cycle assessment: what assessment tools and options are appropriate for nanomaterials; nanoinformatics: how to get the needed information for meaningful assessments; and policy and regulatory matters: what is the current landscape. The National Institute for Occupational Safety and Health (NIOSH) is a co-sponsor of this event.

Nanotechnology Now's columnist Lynn L. Bergeson will speak at the fifth international symposium on nanotechnology, occupational and environmental health

Washington, DC | Posted on August 1st, 2011

B&C has made a concerted effort to be in the forefront of the science policy debate involving nanotechnologies and other emerging technologies. Ms. Bergeson and other professionals at B&C counsel clients on health, safety, science policy, and related legal and regulatory aspects of nanotechnology and emerging transformative technologies, and on more traditional chemical product approval matters. Ms. Bergeson serves on a number of domestic and international nanotechnology standard setting and governance committees, and writes and lectures frequently on nano-related topics. Recent publications include: Nanotechnology: Environmental Law, Policy, and Business Considerations, ABA (2010); 'New on the Horizon: Nanotechnology,' in Product Liability, ABA (2010) (co-author); Nanotechnology and the Environment, CRC Press (2008) (co-author); and Nanotechnology Deskbook, ELI (2007) (co-author). Ms. Bergeson writes frequently on emerging technologies, and is a regular contributor to the Nanotechnology Industries Association's (NIA) Newsletter (the Newsletter is free to NIA members; subscriptions are available online) and to Nanotechnology Now (available online).

####

For more information, please click here

Copyright © Bergeson & Campbell, P.C.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

The symposium will be held at the Westin Boston Waterfront hotel. Additional information on how to register for the program is available online:

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Govt.-Legislation/Regulation/Funding/Policy

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Researchers develop microbubble scrubber to destroy dangerous biofilms September 19th, 2018

Researchers managed to prevent the disappearing of quantum information September 14th, 2018

New photonic chip promises more robust quantum computers September 14th, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Events/Classes

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project